187 related articles for article (PubMed ID: 24257040)
21. Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
Cisternino S; Chapy H; André P; Smirnova M; Debray M; Scherrmann JM
AAPS J; 2013 Apr; 15(2):299-307. PubMed ID: 23212563
[TBL] [Abstract][Full Text] [Related]
22. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
23. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
[TBL] [Abstract][Full Text] [Related]
24. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
[TBL] [Abstract][Full Text] [Related]
25. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A
J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651
[TBL] [Abstract][Full Text] [Related]
26. Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
André P; Debray M; Scherrmann JM; Cisternino S
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1293-304. PubMed ID: 19458607
[TBL] [Abstract][Full Text] [Related]
27. Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Drug Metab Dispos; 2006 Nov; 34(11):1868-74. PubMed ID: 16928787
[TBL] [Abstract][Full Text] [Related]
28. Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
Wang M; Sun Y; Hu B; He Z; Chen S; Qi D; An H; Wei Y
Curr Drug Deliv; 2022; 19(4):508-517. PubMed ID: 34238184
[TBL] [Abstract][Full Text] [Related]
29. Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.
Okura T; Ito R; Ishiguro N; Tamai I; Deguchi Y
Life Sci; 2007 Apr; 80(17):1564-71. PubMed ID: 17307202
[TBL] [Abstract][Full Text] [Related]
30. Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters.
Tun T; Kang YS
Biomol Ther (Seoul); 2017 Jul; 25(4):441-451. PubMed ID: 28554202
[TBL] [Abstract][Full Text] [Related]
31. Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.
Ruan Y; Li X; You L; Chen J; Shen Y; Zhang J; Yuan Y; Kang L; Qin C; Wu C
Mol Pharm; 2021 Jun; 18(6):2198-2207. PubMed ID: 33956455
[TBL] [Abstract][Full Text] [Related]
32. Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1.
Tsuda M; Terada T; Asaka J; Ueba M; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F593-8. PubMed ID: 17047166
[TBL] [Abstract][Full Text] [Related]
33. Organic cation transport by rat hepatocyte basolateral membrane vesicles.
McKinney TD; Hosford MA
Am J Physiol; 1992 Dec; 263(6 Pt 1):G939-46. PubMed ID: 1335694
[TBL] [Abstract][Full Text] [Related]
34. Organic cation rhodamines for screening organic cation transporters in early stages of drug development.
Ugwu MC; Oli A; Esimone CO; Agu RU
J Pharmacol Toxicol Methods; 2016; 82():9-19. PubMed ID: 27235784
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
36. Donepezil, tacrine and alpha-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB).
Kang YS; Lee KE; Lee NY; Terasaki T
Arch Pharm Res; 2005 Apr; 28(4):443-50. PubMed ID: 15918518
[TBL] [Abstract][Full Text] [Related]
37. Contribution of pannexin 1 and connexin 43 hemichannels to extracellular calcium-dependent transport dynamics in human blood-brain barrier endothelial cells.
Kaneko Y; Tachikawa M; Akaogi R; Fujimoto K; Ishibashi M; Uchida Y; Couraud PO; Ohtsuki S; Hosoya K; Terasaki T
J Pharmacol Exp Ther; 2015 Apr; 353(1):192-200. PubMed ID: 25670633
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies.
Macdonald C; Shao D; Oli A; Agu RU
J Drug Target; 2013 Jan; 21(1):97-106. PubMed ID: 23050869
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.
Chapy H; Goracci L; Vayer P; Parmentier Y; Carrupt PA; Declèves X; Scherrmann JM; Cisternino S; Cruciani G
Br J Pharmacol; 2015 Oct; 172(20):4888-904. PubMed ID: 26220580
[TBL] [Abstract][Full Text] [Related]
40. Organic cation transport in human renal brush-border membrane vesicles.
Ott RJ; Hui AC; Yuan G; Giacomini KM
Am J Physiol; 1991 Sep; 261(3 Pt 2):F443-51. PubMed ID: 1832266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
